<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO>WSJ900808-0090</DOCNO><DOCID>900808-0090.</DOCID><HL>   Technology Brief -- Epitope Inc.:   FDA Clears Clinical Trials   For Company's AIDS Test</HL><DATE>08/08/90</DATE><SO>WALL STREET JOURNAL (J), PAGE B4</SO><CO>   EPT</CO><IN>MEDICAL AND BIOTECHNOLOGY (MTC)</IN><GV>FOOD AND DRUG ADMINISTRATION (FDA)</GV><LP>   Epitope Inc. said the Food and Drug Administrationapproved its application to begin human clinical trials on asaliva-based AIDS diagnostic test.   Epitope said preclinical trials show the test to be asaccurate as blood tests taken to detect the AIDS virus. Theclinical trials, expected to last for nine months, will beconducted in hospitals, laboratories, medical centers anddental schools in San Francisco; Tampa, Fla.; Portland, Ore.;New York; and Chicago.</LP><TEXT>   The Beaverton, Ore., biotechnology concern said its systemuses a saliva collection kit. The results are placed in asealed tube and sent to company labs for testing.</TEXT></DOC>